期刊文献+

还原型谷胱甘肽治疗肝脏疾病的药理作用及临床应用研究进展 被引量:4

Research progress on pharmacological action and clinical application of reduced glutathione in the treatment of liver diseases
下载PDF
导出
摘要 谷胱甘肽是一种多肽药物,一种重要的巯基化合物,可参与细胞活性氧代谢,具有抗氧化、抗肿瘤、增强免疫力等功效,临床上用于肝脏、肾脏、胰腺、肿瘤等疾病的治疗。本文对还原型谷胱甘肽(GSH)的药理作用及其对肝脏损伤和疾病治疗的临床应用进行综述,为进一步合理利用其药物治疗提供依据。 Glutathione is a peptide drug,an important sulfhydryl compound,which can participate in cellular reactive oxygen metabolism and has antioxidant,antitumor and immunity enhancing effects,and is clinically used in the treatment of liver,kidney,pancreas and tumor diseases.In this paper,the pharmacological action of reduced glutathione(GSH)and its clinical applications for liver injury and disease treatment are reviewed to provide a basis for further rational use of its drug therapy.
作者 陈鑫 李丛建 CHEN Xin;LI Cong-jian(Zhejiang Lepu Pharmaceutical Co.,Ltd.,Taizhou 318000,China)
出处 《中国现代药物应用》 2023年第7期167-169,共3页 Chinese Journal of Modern Drug Application
关键词 还原型谷胱甘肽 药理作用 肝损害 临床应用 Reduced glutathione Pharmacological action Liver damage Clinical application
  • 相关文献

参考文献29

二级参考文献380

共引文献496

同被引文献69

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部